Contineum Therapeutics Inc (CTNM)

Finanzdaten der Contineum Therapeutics Inc-Aktie (CTNM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	3.10%17.43	16.90	17.12	14.93	17.90
Research and Development	9.05%12.70	11.65	12.76	10.99	14.06
Operating Income/Loss	3.10%-17.43	-16.90	-17.12	-14.93	-17.90
Nonoperating Income/Loss	7.11%2.27	2.45	1.96	2.41	1.86
	4.83%-15.15	-14.46	-15.16	-12.79	-16.04
Attributable To Parent	4.83%-15.15	-14.46	-15.16	-12.79	-16.04
Basic Average Shares	0.34%37.47	37.34	1.07	28.12	25.90
Diluted Average Shares	0.34%37.47	37.34	-	-	-
Basic Earnings Per Share	2.56%-0.40	-0.39	-0.49	-0.45	-0.62
Diluted Earnings Per Share	2.56%-0.40	-0.39	-	-	-